Guillermo García‐Effrón

Author

Also Known As

G. GARCIA-EFFRON, G. GARCIA‐EFFRON, G. Garcia-Effron, G. García-Effron, G. García-Effrón, G. García–Effron, Guillermo Garcia Effron, Guillermo Garcia-Effron, Guillermo Garcia‐Effron, Guillermo García Effron

128

Publications

5.9K

Citations

H-Index

Concepts

All Affiliations

Universidad Nacional del Litoral Centro Científico Tecnológico - Santa Fe Instituto de Salud Carlos III Rutgers New Jersey Medical School Consejo Nacional de Investigaciones Científicas y Técnicas

About

Guillermo García‐Effrón is an author at Universidad Nacional del Litoral specializing in microbiology, medicine, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	36	3.3K
2	Health Sciences	13	13	1.5K
3	Biochemistry	6	6	966
4	Engineering	4	4	520
5	Natural Sciences	2	2	172

Guillermo García‐Effrón

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
A New <i>Aspergillus fumigatus</i> Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of <i>cyp51A</i> Alterations Emilia Mellado, Guillermo García‐Effrón, Laura Alcázar‐Fuoli, Antimicrobial Agents and Chemotherapy	2007	489
Effect of <i>Candida glabrata FKS1</i> and <i>FKS2</i> Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β- <scp>d</scp> -Glucan Synthase: Implication for the Existing Susceptibility Breakpoint Guillermo García‐Effrón, Samuel Lee, Steven Park, Antimicrobial Agents and Chemotherapy BiosynthesisEngineeringCellular EnzymologyBiochemistryMedicine	2009	310
A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in <i>Candida parapsilosis</i> , <i>Candida orthopsilosis</i> , and <i>Candida metapsilosis</i> Accounts for Reduced Echinocandin Susceptibility Guillermo García‐Effrón, Säntosh K. Katiyar, Steven Park, Antimicrobial Agents and Chemotherapy Reduced Echinocandin SusceptibilityMedical MicrobiologyAntifungal AgentHealth SciencesMicrobial Pathogens	2008	306
Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints Guillermo García‐Effrón, Steven Park, David S. Perlin Antimicrobial Agents and Chemotherapy Antifungal AgentHot Spot 1Susceptibility BreakpointBiochemistryFungal Cell Biology	2008	250
Substitutions at Methionine 220 in the 14α-Sterol Demethylase (Cyp51A) of <i>Aspergillus fumigatus</i> Are Responsible for Resistance In Vitro to Azole Antifungal Drugs Emilia Mellado, Guillermo García‐Effrón, Laura Alcázar‐Fuoli, Antimicrobial Agents and Chemotherapy Aspergillus FumigatusFungal Cell BiologyGeneticsDrug ResistanceBiosynthesis	2004	204
Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs Yong-Qiang Zhang, Soledad Gamarra, Guillermo García‐Effrón, PLoS Pathogens	2010	203
Breakthrough Invasive Candidiasis in Patients on Micafungin Christopher D. Pfeiffer, Guillermo García‐Effrón, Aimee K. Zaas, Journal of Clinical Microbiology	2010	198
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance Ronen Ben‐Ami, Guillermo García‐Effrón, Russell E. Lewis, The Journal of Infectious Diseases Fks1 MutationsEchinocandin ResistanceEngineeringC. Albicans VirulenceGenetics	2011	162
Echinocandin Susceptibility Testing of<i>Candida</i>Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media Maiken Cavling Arendrup, Guillermo García‐Effrón, Cornelia Lass‐Flörl, Antimicrobial Agents and Chemotherapy Diagnostic MycologyPathogen DetectionSusceptibility TestsGeneticsPathology	2009	155
Ergosterol biosynthesis pathway in Aspergillus fumigatus Laura Alcázar‐Fuoli, Emilia Mellado, Guillermo García‐Effrón, Steroids Ergosterol Biosynthesis PathwayBiosynthesisBiochemistryMicrobiologyFungal Cell Factory	2007	154

Page 1